ICD-10-CM/PCS MS-DRG v41.0 Definitions Manual
![Previous Page [Alt-p]](bakpg.png){kind=small}
![Up a level [Alt-u]](uptop.png){kind=small}
![Next Page [Alt-n]](fwdpg.png){kind=small}
DRAFT
ICD-10-CM/PCS MS-DRG v41.0 Definitions Manual |
> | |||
| Skip to content | |
|
|
| MDC 17 Myeloproliferative diseases and disorders, poorly differentiated neoplasms |
| Chemotherapy without acute leukemia as secondary diagnosis |
| MCC | CC | DRG |
|---|---|---|
| Yes | n/a | 846 |
| No | Yes | 847 |
| No | No | 848 |
DRG 846 CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC
DRG 847 CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC
DRG 848 CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC
PRINCIPAL DIAGNOSIS
| Z08 | Encounter for follow-up examination after completed treatment for malignant neoplasm |
| Z5111 | Encounter for antineoplastic chemotherapy |
| Z5112 | Encounter for antineoplastic immunotherapy |
|
Centers for Medicare & Medicaid Services, 7500 Security Boulevard Baltimore, MD 21244 01 Mar 2023 06:12:40 CMS, code-revision=344, description-revision=1357 |